Page last updated: 2024-11-13

6-fluoro-5,7-dibromo-2-methyl-1-formyl-1,2,3,4-tetrahydroquinoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-fluoro-5,7-dibromo-2-methyl-1-formyl-1,2,3,4-tetrahydroquinoline: an Epac1 inhibitor; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID21781066
CHEMBL ID4159565
SCHEMBL ID17070839
MeSH IDM0593842

Synonyms (20)

Synonym
ce3f4
143703-25-7
AKOS025142022
5,7-dibromo-6-fluoro-3,4-dihydro-2-methyl-1(2h)-quinolinecarboxaldehyde
SCHEMBL17070839
5,7-dibromo-6-fluoro-2-methyl-1,2,3,4-tetrahydroquinoline-1-carbaldehyde
ce-3-f-4; ce 3 f 4; ce-3f4; ce 3f4
BCP26262
HY-108539
CS-0029107
AS-16940
5,7-dibromo-6-fluoro-2-methyl-3,4-dihydroquinoline-1(2h)-carbaldehyde ,
EX-A4830
gtpl10624
5,7-dibromo-6-fluoro-2-methyl-3,4-dihydro-2h-quinoline-1-carbaldehyde
CHEMBL4159565
6-fluoro-5,7-dibromo-2-methyl-1-formyl-1,2,3,4-tetrahydroquinoline
cid 21781066
AC-36626
F90309
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1505263Inhibition of recombinant human GST-tagged EPAC1 (149 to 881 residues) expressed in Escherichia coli Rosetta 2(DE3) assessed as reduction in guanine nucleotide exchange activity at 10 uM using BODIPY-labeled GDP loaded Rap1A by fluorescence assay relative2017ACS medicinal chemistry letters, Nov-09, Volume: 8, Issue:11
Structure-Activity Relationship Studies with Tetrahydroquinoline Analogs as EPAC Inhibitors.
AID1505264Inhibition of recombinant human GST-tagged EPAC1 (149 to 881 residues) expressed in Escherichia coli Rosetta 2(DE3) assessed as reduction in guanine nucleotide exchange activity at 50 uM using BODIPY-labeled GDP loaded Rap1A by fluorescence assay relative2017ACS medicinal chemistry letters, Nov-09, Volume: 8, Issue:11
Structure-Activity Relationship Studies with Tetrahydroquinoline Analogs as EPAC Inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (81.82)24.3611
2020's2 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.10 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.58 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]